1
|
Trindade GADM, Alves LA, Lazo REL, Dallabrida KG, Reolon JB, Bonini JS, Nunes KC, Garcia FP, Nakamura CV, Rego FGDM, Pontarolo R, Sari MHM, Ferreira LM. Polysaccharide-Stabilized Semisolid Emulsion with Vegetable Oils for Skin Wound Healing: Impact of Composition on Physicochemical and Biological Properties. Pharmaceutics 2024; 16:1426. [PMID: 39598549 PMCID: PMC11597777 DOI: 10.3390/pharmaceutics16111426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2024] [Revised: 11/02/2024] [Accepted: 11/04/2024] [Indexed: 11/29/2024] Open
Abstract
Background/Objectives: The demand for natural-based formulations in chronic wound care has increased, driven by the need for biocompatible, safe, and effective treatments. Natural polysaccharide-based emulsions enriched with vegetable oils present promising benefits for skin repair, offering structural support and protective barriers suitable for sensitive wound environments. This study aimed to develop and evaluate semisolid polysaccharide-based emulsions for wound healing, incorporating avocado (Persea gratissima) and blackcurrant (Ribes nigrum) oils (AO and BO, respectively). Both gellan gum (GG) and kappa-carrageenan (KC) were used as stabilizers due to their biocompatibility and gel-forming abilities. Methods: Four formulations were prepared (F1-GG-AO; F2-KC-AO; F3-GG-BO; F4-KC-BO) and evaluated for physicochemical properties, spreadability, rheology, antioxidant activity, occlusive and bioadhesion potential, biocompatibility, and wound healing efficacy using an in vitro scratch assay. Results: The pH values (4.74-5.06) were suitable for skin application, and FTIR confirmed excipient compatibility. The formulations showed reduced occlusive potential, pseudoplastic behavior with thixotropy, and adequate spreadability (7.13-8.47 mm2/g). Lower bioadhesion indicated ease of application and removal, enhancing user comfort. Formulations stabilized with KC exhibited superior antioxidant activity (DPPH scavenging) and fibroblast biocompatibility (CC50% 390-589 µg/mL) and were non-hemolytic. Both F2-KC-AO and F4-KC-BO significantly improved in vitro wound healing by promoting cell migration compared to other formulations. Conclusions: These findings underscore the potential of these emulsions for effective wound treatment, providing a foundation for developing skin care products that harness the therapeutic properties of polysaccharides and plant oils in a natural approach to wound care.
Collapse
Affiliation(s)
- Giovanna Araujo de Morais Trindade
- Center for Studies in Biopharmacy, Pos-Graduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, PR, Brazil; (G.A.d.M.T.); (L.A.A.); (R.E.L.L.); (R.P.)
| | - Laiene Antunes Alves
- Center for Studies in Biopharmacy, Pos-Graduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, PR, Brazil; (G.A.d.M.T.); (L.A.A.); (R.E.L.L.); (R.P.)
| | - Raul Edison Luna Lazo
- Center for Studies in Biopharmacy, Pos-Graduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, PR, Brazil; (G.A.d.M.T.); (L.A.A.); (R.E.L.L.); (R.P.)
| | - Kamila Gabrieli Dallabrida
- Department of Pharmacy, Midwestern State University, Guarapuava 85040-167, PR, Brazil; (K.G.D.); (J.B.R.); (J.S.B.)
| | - Jéssica Brandão Reolon
- Department of Pharmacy, Midwestern State University, Guarapuava 85040-167, PR, Brazil; (K.G.D.); (J.B.R.); (J.S.B.)
| | - Juliana Sartori Bonini
- Department of Pharmacy, Midwestern State University, Guarapuava 85040-167, PR, Brazil; (K.G.D.); (J.B.R.); (J.S.B.)
| | - Karine Campos Nunes
- Laboratory of Technological Innovation in the Development of Pharmaceuticals and Cosmetics, Department of Basic Health Sciences, State University of Maringá, Maringá 87020-900, PR, Brazil; (K.C.N.); (F.P.G.); (C.V.N.)
| | - Francielle Pelegrin Garcia
- Laboratory of Technological Innovation in the Development of Pharmaceuticals and Cosmetics, Department of Basic Health Sciences, State University of Maringá, Maringá 87020-900, PR, Brazil; (K.C.N.); (F.P.G.); (C.V.N.)
| | - Celso Vataru Nakamura
- Laboratory of Technological Innovation in the Development of Pharmaceuticals and Cosmetics, Department of Basic Health Sciences, State University of Maringá, Maringá 87020-900, PR, Brazil; (K.C.N.); (F.P.G.); (C.V.N.)
| | | | - Roberto Pontarolo
- Center for Studies in Biopharmacy, Pos-Graduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, PR, Brazil; (G.A.d.M.T.); (L.A.A.); (R.E.L.L.); (R.P.)
| | | | - Luana Mota Ferreira
- Center for Studies in Biopharmacy, Pos-Graduate Program in Pharmaceutical Sciences, Department of Pharmacy, Federal University of Paraná, Curitiba 80210-170, PR, Brazil; (G.A.d.M.T.); (L.A.A.); (R.E.L.L.); (R.P.)
| |
Collapse
|
2
|
Wang M, Xiang YH, Liu M, Jiang S, Guo JY, Jin XY, Sun HF, Zhang N, Wang ZG, Liu JX. The application prospects of sacha inchi ( Plukenetia volubilis linneo) in rheumatoid arthritis. Front Pharmacol 2024; 15:1481272. [PMID: 39484157 PMCID: PMC11524839 DOI: 10.3389/fphar.2024.1481272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2024] [Accepted: 10/04/2024] [Indexed: 11/03/2024] Open
Abstract
Sacha Inchi (Plukenetia volubilis L) (SI) is a traditional natural medicine from tropical rainforests of Amazon region in South America. As a raw material for edible oil, it has various pharmacological effects such as antioxidant, anti-inflammatory, hypolipidemia, and blood pressure lowering, which have attracted increasing attentions of pharmacists. This has prompted researchers to explore its pharmacological effects for potential applications in certain diseases. Among these, the study of its anti-inflammatory effects has become a particularly interesting topic, especially in rheumatoid arthritis (RA). RA is a systemic autoimmune disease, and often accompanied by chronic inflammatory reactions. Despite significant progress in its treatment, there is still an urgent need to find effective anti-RA drugs in regard to safety. This review summarizes the potential therapeutic effects of SI on RA by modulating gut microbiota, targeting inflammatory cells and pathways, and mimicking biologic antibody drugs, predicting the application prospects of SI in RA, and providing references for research aimed at using SI to treat RA.
Collapse
Affiliation(s)
- Min Wang
- School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
- Sino-Pakistan Center on Traditional Chinese Medicine, School of Pharmaceutical Sciences, School of Basic Medical Sciences, China-Pakistan International Science and Technology Innovation Cooperation Base for Ethnic Medicine Development in Hunan Province, Hunan University of Medicine, Huaihua, Hunan, China
| | - Yin-Hong Xiang
- Sino-Pakistan Center on Traditional Chinese Medicine, School of Pharmaceutical Sciences, School of Basic Medical Sciences, China-Pakistan International Science and Technology Innovation Cooperation Base for Ethnic Medicine Development in Hunan Province, Hunan University of Medicine, Huaihua, Hunan, China
| | - Mei Liu
- Sino-Pakistan Center on Traditional Chinese Medicine, School of Pharmaceutical Sciences, School of Basic Medical Sciences, China-Pakistan International Science and Technology Innovation Cooperation Base for Ethnic Medicine Development in Hunan Province, Hunan University of Medicine, Huaihua, Hunan, China
- School of Pharmaceutical Sciences, University of South China, Hengyang, Hunan, China
| | - Shan Jiang
- School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
| | - Jia-ying Guo
- School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
| | - Xiao-yan Jin
- School of Pharmaceutical Sciences, Xinjiang medical University, Wulumuqi, Xinjiang, China
| | - Hui-feng Sun
- School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
| | - Ning Zhang
- School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
- Sino-Pakistan Center on Traditional Chinese Medicine, School of Pharmaceutical Sciences, School of Basic Medical Sciences, China-Pakistan International Science and Technology Innovation Cooperation Base for Ethnic Medicine Development in Hunan Province, Hunan University of Medicine, Huaihua, Hunan, China
| | - Zhi-Gang Wang
- School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
| | - Jian-xin Liu
- Sino-Pakistan Center on Traditional Chinese Medicine, School of Pharmaceutical Sciences, School of Basic Medical Sciences, China-Pakistan International Science and Technology Innovation Cooperation Base for Ethnic Medicine Development in Hunan Province, Hunan University of Medicine, Huaihua, Hunan, China
- School of Pharmaceutical Sciences, University of South China, Hengyang, Hunan, China
| |
Collapse
|
3
|
Zhang Y, Zhao W, Liao J, Zhang Y, Wang L, Li P, Du B. Evaluation of the therapeutic effect of Sacha inchi oil in atopic dermatitis mice. Int Immunopharmacol 2024; 138:112552. [PMID: 38917521 DOI: 10.1016/j.intimp.2024.112552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2024] [Revised: 06/03/2024] [Accepted: 06/20/2024] [Indexed: 06/27/2024]
Abstract
Atopic dermatitis (AD) is a prevalent inflammatory skin condition characterized by a multifaceted pathogenesis, which encompasses immune system signaling dysregulation, compromised skin barrier function, and genetic influencers. Sacha inchi (Plukenetia volubilis L.) oil (SIO) has demonstrated potent anti-inflammatory and antioxidant properties, however, the mechanism underlying the beneficial effects of SIO on AD remains unclear. This study aims to investigate the anti-AD effect of SIO and its possible molecular mechanism in mice with AD. The results demonstrated that SIO significantly reduced the degree of skin lesions and scratching, and improved the skin thickness and mast cell infiltration in AD mice. Furthermore, SIO significantly reduced the levels of immunoglobulin E, histamine and thymic stromal lymphopoietin in serum of AD mice. Additionally, it inhibited the expression of tumor necrosis factor-γ, interferon-γ, interleukin-2, interleukin-4, interleukin 1β and other inflammatory cytokines in the lesions skin of mice. The Western blotting analysis revealed that SIO exhibited an upregulatory effect on the protein expression of filaggrin and loricrin, while concurrently exerting inhibitory effects on the protein expression and phosphorylation levels of P38, ERK, NF-κB, and IκBα within their respective signaling pathways. Consequently, it can be inferred that SIO exerts a significant anti-atopic dermatitis effect by modulating the P38, ERK, NF-κB, and IκBα signaling pathways. This study contributes to expand the research and development potential of SIO, and provides novel insights and potential therapeutic strategies for AD treatment.
Collapse
Affiliation(s)
- Yuwei Zhang
- College of Food Science, South China Agricultural University, Guangzhou, 510642, China
| | - Wenjun Zhao
- College of Food Science, South China Agricultural University, Guangzhou, 510642, China
| | - Jingru Liao
- College of Food Science, South China Agricultural University, Guangzhou, 510642, China
| | - Yixiang Zhang
- College of Food Science, South China Agricultural University, Guangzhou, 510642, China
| | - Lieyu Wang
- College of Food Science, South China Agricultural University, Guangzhou, 510642, China
| | - Pan Li
- College of Food Science, South China Agricultural University, Guangzhou, 510642, China
| | - Bing Du
- College of Food Science, South China Agricultural University, Guangzhou, 510642, China.
| |
Collapse
|
4
|
Lima TDPDL, Canelas CADA, Dutra JDCF, Rodrigues APD, Brígida RTSS, Concha VOC, da Costa FAM, Passos MF. Poly (ε-caprolactone)-Based Scaffolds with Multizonal Architecture: Synthesis, Characterization, and In Vitro Tests. Polymers (Basel) 2023; 15:4403. [PMID: 38006127 PMCID: PMC10674666 DOI: 10.3390/polym15224403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 09/25/2023] [Accepted: 10/03/2023] [Indexed: 11/26/2023] Open
Abstract
Tissue engineering is vital in treating injuries and restoring damaged tissues, aiming to accelerate regeneration and optimize the complex healing process. In this study, multizonal scaffolds, designed to mimic tissues with bilayer architecture, were prepared using the rotary jet spinning technique (RJS scaffolds). Polycaprolactone and different concentrations of alginate hydrogel (2, 4, and 6% m/v) were used. The materials were swollen in pracaxi vegetable oil (PO) (Pentaclethra macroloba) and evaluated in terms of surface morphology, wettability, functional groups, thermal behavior, crystallinity, and cytotoxicity. X-ray diffraction (XRD) showed the disappearance of the diffraction peak 2θ = 31.5° for samples from the polycaprolactone/pracaxi/alginate (PCLOA) group, suggesting a reduction of crystallinity according to the presence of PO and semi-crystalline structure. Wettability gradients (0 to 80.91°) were observed according to the deposition layer and hydrogel content. Pore diameters varied between 9.27 μm and 37.57 μm. Molecular interactions with the constituents of the formulation were observed via infrared spectra with Fourier transform (FTIR), and their influence was detected in the reduction of the maximum degradation temperature within the groups of scaffolds (polycaprolactone/alginate (PCLA) and PCLOA) about the control. In vitro tests indicated reduced cell viability in the presence of alginate hydrogel and PO, respectively.
Collapse
Affiliation(s)
- Tainara de Paula de Lima Lima
- Technological Development Group in Biopolymers and Biomaterials from the Amazon, Materials Science and Engineering Program, Federal University of Pará, Ananindeua 67130-660, PA, Brazil;
| | | | - Joyce da Cruz Ferraz Dutra
- Microbiology Department, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, MG, Brazil;
| | - Ana Paula Drummond Rodrigues
- Electron Microscopy Laboratory, Evandro Chagas Institute, Ministry of Health, Belém 66093-020, PA, Brazil; (A.P.D.R.); (R.T.S.S.B.)
| | | | | | | | - Marcele Fonseca Passos
- Technological Development Group in Biopolymers and Biomaterials from the Amazon, Materials Science and Engineering Program, Federal University of Pará, Ananindeua 67130-660, PA, Brazil;
- Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil; (C.A.d.A.C.); (F.A.M.d.C.)
| |
Collapse
|
5
|
Guidoni M, de Sousa Júnior AD, Aragão VPM, de Melo Costa Pereira T, Dos Santos WC, Monteiro FC, Guimarães MCC, Fronza M. Liposomal stem cell extract formulation from Coffea canephora shows outstanding anti-inflammatory activity, increased tissue repair, neocollagenesis and neoangiogenesis. Arch Dermatol Res 2023; 315:491-503. [PMID: 36114867 DOI: 10.1007/s00403-022-02388-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Revised: 07/26/2022] [Accepted: 09/07/2022] [Indexed: 11/02/2022]
Abstract
Coffea canephora plant stem cells can have bioactive compounds with tissue repairing and anti-inflammatory action. This study aimed to develop a liposomal stem cell extract formulation obtained from the leaves of C. canephora (LSCECC) and to investigate its capacity to contribute to the dynamic mechanisms of tissue repair. The liposome cream was developed and characterized through the dynamic light scattering technique, atomic force microscopy, and transmission electron microscopy. The excisional full-thickness skin wound model was used and daily topically treated with the LSCECC formulation or vehicle control. On days 2, 7, 14, and 21 after wounding, five rats from each group were euthanized and the rates of wound closure and re-epithelialization were evaluated using biochemical and histological tests. LSCECC resulted in faster re-epithelialization exhibiting a significant reduction in wound area of 36.4, 42.4, and 87.5% after 7, 10, and 14 days, respectively, when compared to vehicle control. LSCECC treated wounds exhibited an increase in granular tissue and a proper inflammatory response mediated by the reduction of pro-inflammatory cytokines like TNF-α and IL-6 and an increase of IL-10. Furthermore, wounds treated with LSCECC showed an increase in the deposition and organization of collagen fibers at the wound site and improved scar tissue quality due to the increase in transforming growth factor-beta and vascular endothelial growth factor. Our data showed that LSCECC improves wound healing, the formation of extracellular matrix, modulates inflammatory response, and promotes neovascularization being consider a promising bioactive extract to promote and support healthy skin. The graphical presents the action of LSCECC in all four phases of wound healing and tissue repair. The LSCECC can reduce the inflammatory infiltrate in the inflammatory phase by decreasing the pro-inflammatory cytokines like IL-6 and TNF-α, in addition to maintaining this modulation through lesser activation and recruitment of macrophages. The LSCECC can also increase the release of IL-10, an anti-inflammatory cytokine, decreasing local edema. The increase in VEGF provides neovascularization and the supply of nutrients to newly repaired tissue. Finally, signaling via TGF-β increases the production and organization of collagen fibers in the remodeling phase.
Collapse
Affiliation(s)
- Marcio Guidoni
- Programa de Pós-Graduação em Ciências Farmacêuticas, Laboratório de Produtos Naturais, Universidade Vila Velha-UVV, Av. Comissário José Dantas de Melo, n°21, Boa Vista, Vila Velha, ES, 29102-920, Brazil
| | - Antônio Domingos de Sousa Júnior
- Programa de Pós-Graduação em Ciências Farmacêuticas, Laboratório de Produtos Naturais, Universidade Vila Velha-UVV, Av. Comissário José Dantas de Melo, n°21, Boa Vista, Vila Velha, ES, 29102-920, Brazil
| | - Victor Paulo Mesquita Aragão
- Pesquisador do Instituto Capixaba de Ciências e Administração (ICCA), Programa de Desenvolvimento Científico e Tecnológico Regional (FAPES/CNPq), Vila Velha, ES, Brazil
| | - Thiago de Melo Costa Pereira
- Programa de Pós-Graduação em Ciências Farmacêuticas, Laboratório de Produtos Naturais, Universidade Vila Velha-UVV, Av. Comissário José Dantas de Melo, n°21, Boa Vista, Vila Velha, ES, 29102-920, Brazil
| | - Wedson Correa Dos Santos
- Programa de Pós-Graduação em Ciências Farmacêuticas, Laboratório de Produtos Naturais, Universidade Vila Velha-UVV, Av. Comissário José Dantas de Melo, n°21, Boa Vista, Vila Velha, ES, 29102-920, Brazil
| | - Flavio Cunha Monteiro
- Pesquisador do Instituto Capixaba de Ciências e Administração (ICCA), Programa de Desenvolvimento Científico e Tecnológico Regional (FAPES/CNPq), Vila Velha, ES, Brazil
| | | | - Marcio Fronza
- Programa de Pós-Graduação em Ciências Farmacêuticas, Laboratório de Produtos Naturais, Universidade Vila Velha-UVV, Av. Comissário José Dantas de Melo, n°21, Boa Vista, Vila Velha, ES, 29102-920, Brazil.
- Pesquisador do Instituto Capixaba de Ciências e Administração (ICCA), Programa de Desenvolvimento Científico e Tecnológico Regional (FAPES/CNPq), Vila Velha, ES, Brazil.
| |
Collapse
|
6
|
Carvalho GR, Braz DS, Gonçalves TCO, Aires R, Côco LZ, Guidoni M, Fronza M, Endringer DC, Júnior ADS, Campos-Toimil M, Nogueira BV, Vasquez EC, Campagnaro BP, Pereira TMC. Development and Evaluation of Virola oleifera Formulation for Cutaneous Wound Healing. Antioxidants (Basel) 2022; 11:antiox11091647. [PMID: 36139721 PMCID: PMC9495449 DOI: 10.3390/antiox11091647] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 08/19/2022] [Accepted: 08/23/2022] [Indexed: 11/21/2022] Open
Abstract
In regions adjacent to the Brazilian Atlantic Forest, Virola oleifera (VO) resin extract has been popularly used for decades as a skin and mucosal healing agent. However, this antioxidant-rich resin has not yet been investigated in wound healing, whose physiological process might also be aggravated by oxidative stress-related diseases (e.g., hypertension/diabetes). Our aim, therefore, was to investigate whether VO resin presents healing effects through an innovative cream for topical applications. For this, adult male Wistar rats were divided into four groups. Then, four 15 mm excisions were performed on the shaved skin. All treatments were applied topically to the wound area daily. At the end of experiments (0, 3rd, and 10th days) macroscopic analysis of wound tissue contraction and histological analysis of inflammatory cell parameters were performed. The group treated with VO cream showed the best wound contraction (15%, p < 0.05) and reduced levels of lipid peroxidation and protein oxidation (118% and 110%, p < 0.05, respectively) compared to the control group. Our results demonstrated the healing capacity of a new formulation prepared with VO, which could be, at least in part, justified by antioxidant mechanisms that contribute to re-epithelialization, becoming a promising dermo-cosmetic for the treatment of wound healing.
Collapse
Affiliation(s)
- Glaucimeire R. Carvalho
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Débora S. Braz
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Talita C. O. Gonçalves
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Rafaela Aires
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Larissa Z. Côco
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Marcio Guidoni
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Marcio Fronza
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Denise C. Endringer
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Antonio D. S. Júnior
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Manuel Campos-Toimil
- Physiology and Pharmacology of Chronic Diseases (FIFAEC), Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Breno V. Nogueira
- Laboratory of Translational Physiology, Physiological Sciences Graduate Program, Federal University of Espírito Santo, Vitoria 29047-105, Brazil
| | - Elisardo C. Vasquez
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
- Physiology and Pharmacology of Chronic Diseases (FIFAEC), Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - Bianca P. Campagnaro
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
| | - Thiago M. C. Pereira
- Pharmaceutical Sciences Graduate Program, Vila Velha University (UVV), Vila Velha 29102-920, Brazil
- Federal Institute of Education, Science and Technology (IFES), Vila Velha 29106-010, Brazil
- Correspondence: ; Tel.: +55-(27)-3421-2001
| |
Collapse
|
7
|
Ginel PJ, Negrini J, Guerra R, Lucena R, Ruiz-Campillo MT, Mozos E. Effect of topical ozonated sunflower oil on second intention wound healing in turtles: a randomised experimental study. J Vet Sci 2021; 22:e27. [PMID: 33774942 PMCID: PMC8007438 DOI: 10.4142/jvs.2021.22.e27] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Revised: 01/19/2021] [Accepted: 02/04/2021] [Indexed: 12/12/2022] Open
Abstract
Background Ozone is an antimicrobial agent that in experimental and case-control studies has been found to exert a positive effect on wound healing. Wild and pet chelonians frequently present insidious wounds exhibiting secondary infections and/or delayed healing. Objectives Evaluate the effects of topical ozonated sunflower oil on second-intention healing of acute experimental skin wounds in red-eared sliders (Trachemys scripta elegans). Methods Randomised within-subject controlled study; Group 1 (n = 24) was used to assess clinical healing features; Group 2 (n = 12) was used for histological evaluation in which two sets of wounds were biopsied at 2, 7, 14, 21, 28 and 42 days over the course of the cicatrisation process. A single 6 mm diameter wound was made on each rear limb and topical ozonated (950 peroxide value) and non-ozonated sunflower oil were applied daily for one week on treated and contralateral control wounds, respectively. Results Mean wound size was significantly lower in the ozone-treated group at day 28 (p < 0.0001) with differences of clinical relevance (74.04% vs. 93.05% reduction of initial wound size). Histologically, the acute inflammatory reaction was enhanced in treated wounds, with significantly higher numbers of heterophils (p = 0.0016), lymphocytes (p < 0.001) and fibroblasts (p < 0.001). Conclusions Daily topical application of ozonated sunflower oil over the course of one week improved the healing of acute, full-thickness skin wounds in chelonians. This clinical outcome was histologically correlated with an enhanced acute inflammatory reaction, as well as the production and remodelling of collagen fibres.
Collapse
Affiliation(s)
- Pedro J Ginel
- Department of Animal Medicine & Surgery, Faculty of Veterinary Medicine, University of Córdoba, 14071 Córdoba, Spain.
| | - Joao Negrini
- Department of Anatomy & Comparative Pathology, Faculty of Veterinary Medicine, University of Córdoba, 14071 Córdoba, Spain.,Department of Veterinary Medicine, Federal University of Mato Grosso do Sul, 79074-460 Campo Grande, Brazil
| | | | - Rosario Lucena
- Department of Animal Medicine & Surgery, Faculty of Veterinary Medicine, University of Córdoba, 14071 Córdoba, Spain
| | - María T Ruiz-Campillo
- Department of Anatomy & Comparative Pathology, Faculty of Veterinary Medicine, University of Córdoba, 14071 Córdoba, Spain
| | - Elena Mozos
- Department of Anatomy & Comparative Pathology, Faculty of Veterinary Medicine, University of Córdoba, 14071 Córdoba, Spain
| |
Collapse
|
8
|
Pârvănescu (Pană) RD, Watz CG, Moacă EA, Vlaia L, Marcovici I, Macașoi IG, Borcan F, Olariu I, Coneac G, Drăghici GA, Crăiniceanu Z, Flondor (Ionescu) D, Enache A, Dehelean CA. Oleogel Formulations for the Topical Delivery of Betulin and Lupeol in Skin Injuries-Preparation, Physicochemical Characterization, and Pharmaco-Toxicological Evaluation. Molecules 2021; 26:molecules26144174. [PMID: 34299450 PMCID: PMC8305438 DOI: 10.3390/molecules26144174] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2021] [Revised: 07/04/2021] [Accepted: 07/05/2021] [Indexed: 12/26/2022] Open
Abstract
The skin integrity is essential due to its pivotal role as a biological barrier against external noxious factors. Pentacyclic triterpenes stand as valuable plant-derived natural compounds in the treatment of skin injuries due to their anti-inflammatory, antioxidant, antimicrobial, and healing properties. Consequently, the primary aim of the current investigation was the development as well as the physicochemical and pharmaco-toxicological characterization of betulin- and lupeol-based oleogels (Bet OG and Lup OG) for topical application in skin injuries. The results revealed suitable pH as well as organoleptic, rheological, and textural properties. The penetration and permeation of Bet and Lup oleogels through porcine ear skin as well as the retention of both oleogels in the skin were demonstrated through ex vivo studies. In vitro, Bet OG and Lup OG showed good biocompatibility on HaCaT human immortalized cells. Moreover, Bet OG exerted a potent wound-healing property by stimulating the migration of the HaCaT cells. The in ovo results demonstrated the non-irritative potential of the developed formulations. Additionally, the undertaken in vivo investigation indicated a positive effect of oleogels treatment on skin parameters by increasing skin hydration and decreasing erythema. In conclusion, oleogel formulations are ideal for the local delivery of betulin and lupeol in skin disorders.
Collapse
Affiliation(s)
- Ramona Daniela Pârvănescu (Pană)
- Department VIII—Neuroscience, Discipline of Medical Deontology, Bioethics, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania;
| | - Claudia-Geanina Watz
- Department of Pharmaceutical Physics, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania;
- Research Centre for Pharmaco-Toxicological Evaluation, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timișoara, Romania; (I.M.); (I.G.M.); (G.-A.D.); (D.F.); (C.A.D.)
| | - Elena-Alina Moacă
- Research Centre for Pharmaco-Toxicological Evaluation, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timișoara, Romania; (I.M.); (I.G.M.); (G.-A.D.); (D.F.); (C.A.D.)
- Department of Toxicology and Drug Industry, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania
- Correspondence: (E.-A.M.); (L.V.); Tel.: +40-745-762-600 (E.-A.M.); +40-723-570-499 (L.V.)
| | - Lavinia Vlaia
- Department II—Pharmaceutical Technology, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania; (I.O.); (G.C.)
- Formulation and Technology of Drugs Research Center, “Victor Babes” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania
- Correspondence: (E.-A.M.); (L.V.); Tel.: +40-745-762-600 (E.-A.M.); +40-723-570-499 (L.V.)
| | - Iasmina Marcovici
- Research Centre for Pharmaco-Toxicological Evaluation, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timișoara, Romania; (I.M.); (I.G.M.); (G.-A.D.); (D.F.); (C.A.D.)
- Department of Toxicology and Drug Industry, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania
| | - Ioana Gabriela Macașoi
- Research Centre for Pharmaco-Toxicological Evaluation, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timișoara, Romania; (I.M.); (I.G.M.); (G.-A.D.); (D.F.); (C.A.D.)
- Department of Toxicology and Drug Industry, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania
| | - Florin Borcan
- Department of Analytical Chemistry, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timișoara, Romania;
| | - Ioana Olariu
- Department II—Pharmaceutical Technology, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania; (I.O.); (G.C.)
- Formulation and Technology of Drugs Research Center, “Victor Babes” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania
| | - Georgeta Coneac
- Department II—Pharmaceutical Technology, Faculty of Pharmacy, “Victor Babes” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania; (I.O.); (G.C.)
- Formulation and Technology of Drugs Research Center, “Victor Babes” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania
| | - George-Andrei Drăghici
- Research Centre for Pharmaco-Toxicological Evaluation, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timișoara, Romania; (I.M.); (I.G.M.); (G.-A.D.); (D.F.); (C.A.D.)
- Department of Toxicology and Drug Industry, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania
| | - Zorin Crăiniceanu
- Department of Plastic and Reconstructive Surgery, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timișoara, Romania;
| | - Daniela Flondor (Ionescu)
- Research Centre for Pharmaco-Toxicological Evaluation, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timișoara, Romania; (I.M.); (I.G.M.); (G.-A.D.); (D.F.); (C.A.D.)
- Department of Toxicology and Drug Industry, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania
| | - Alexandra Enache
- Department VIII—Neuroscience, Discipline of Forensic Medicine, Bioethics, Deontology and Medical Law, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania;
| | - Cristina Adriana Dehelean
- Research Centre for Pharmaco-Toxicological Evaluation, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, RO-300041 Timișoara, Romania; (I.M.); (I.G.M.); (G.-A.D.); (D.F.); (C.A.D.)
- Department of Toxicology and Drug Industry, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, RO-300041 Timisoara, Romania
| |
Collapse
|
9
|
Leskur D, Perišić I, Romac K, Šušak H, Šešelja Perišin A, Bukić J, Rušić D, Kladar N, Božin B, Modun D. Comparison of mechanical, chemical and physical human models of in vivo skin damage: Randomized controlled trial. Skin Res Technol 2020; 27:208-216. [PMID: 32686217 DOI: 10.1111/srt.12932] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Revised: 06/17/2020] [Accepted: 06/25/2020] [Indexed: 12/01/2022]
Abstract
INTRODUCTION Human in vivo models of skin damage were often used in research of cutaneous disorders. The most commonly used models were tape-stripping as mechanical, sodium lauryl sulphate-induced irritation as chemical and ultraviolet radiation as physical damage model. In regard to differences between models, they were expected to have different responses to damage and recovery, with unique skin parameters' changes over time. OBJECTIVE The aim was to compare skin parameters in three different skin damage models on the same anatomical location, with and without topical treatment. METHODS Four test sites on each forearm were randomly assigned to three skin damage models with the fourth sites on each forearm chosen as a control, undamaged site. Skin parameters were assessed using non-invasive methods. RESULTS Sodium lauryl sulphate irritation caused the strongest damage with delayed reaction to the irritant. Tape stripping leads to highest initial skin barrier disruption but afterwards it showed the fastest skin recovery. Ultraviolet radiation did not affect skin barrier function, but it elevated skin erythema and melanin level. Tested preparation did not lead to changes in measured parameters. CONCLUSION The skin of the participants had different response to three skin damage models with distinct changes of skin parameters and recovery. The trial was registered at ClinicalTrials.gov under the identifier NCT03783819.
Collapse
Affiliation(s)
- Dario Leskur
- Department of Pharmacy, University of Split School of Medicine, Split, Croatia
| | - Ivana Perišić
- Department of Pharmacy, University of Split School of Medicine, Split, Croatia
| | - Kristina Romac
- Department of Pharmacy, University of Split School of Medicine, Split, Croatia
| | - Helena Šušak
- Department of Pharmacy, University of Split School of Medicine, Split, Croatia
| | - Ana Šešelja Perišin
- Department of Pharmacy, University of Split School of Medicine, Split, Croatia
| | - Josipa Bukić
- Department of Pharmacy, University of Split School of Medicine, Split, Croatia
| | - Doris Rušić
- Department of Pharmacy, University of Split School of Medicine, Split, Croatia
| | - Nebojša Kladar
- Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
| | - Biljana Božin
- Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
| | - Darko Modun
- Department of Pharmacy, University of Split School of Medicine, Split, Croatia
| |
Collapse
|